Next Century Growth Investors’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Next Century Growth Investors’s Portfolio DPLO Stock Details DPLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,204,618	Closed	-$41.2M	–	185
2015 Q4	$41.2M	Buy	1,204,618 +55,890	+5%	+$1.74M	1.78%	14
2015 Q3	$33M	Sell	1,148,728 -141,160	-11%	-$6.04M	1.37%	22
2015 Q2	$57.7M	Buy	1,289,888 +223,745	+21%	+$8.42M	1.99%	5
2015 Q1	$36.9M	Sell	1,066,143 -143,108	-12%	-$3.89M	1.3%	19
2014 Q4	$33.1M	Buy	+1,209,251	New	+$29.3M	1.19%	30

Other funds holding DPLO

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $43.3B AUM 29.3% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Next Century Growth Investors's DPLO Position: Q1 2016 in Review

Next Century Growth Investors sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2016, closing a stake of 1,204,618 shares — an estimated $41.2M sold.

Next Century Growth Investors first reported a position in DPLO in Q4 2014 and held it in 5 quarters. The position peaked at $57.7M in Q2 2015. 160 funds tracked by Wall St. Rank hold DPLO as of Q1 2016.

Next Century Growth Investors reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2016 after selling out during the quarter.
Next Century Growth Investors sold 1,204,618 DIPLOMAT PHARMACY, INC. shares in Q1 2016, an estimated $41.2M.
Next Century Growth Investors first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 5 quarters.
Next Century Growth Investors's DIPLOMAT PHARMACY, INC. position peaked at $57.7M in Q2 2015.
160 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2016.

Based on Next Century Growth Investors's 13F filing for Q1 2016, filed 13 May 2016.